NHS confirms all pregnant women with type 1 diabetes to receive CGMs
All pregnant women with type 1 diabetes will now be offered continuous glucose monitoring (CGM), Professor Partha Kar has confirmed.
In January, the NHS pledged in the ten-year plan that it would ensure the technology would be made available to expectant women with the autoimmune condition by 2021.
The announcement was made off the back of the JDRF-funded CONCEPTT study which proved that CGM improved neonatal outcomes.
Professor Kar, National Specialty Advisor for Diabetes for NHS England, has been instrumental in orchestrating this dynamic move.
He said: “I can confirm that NHS England now offers CGM to all pregnant women with type 1 diabetes, which is a huge milestone. The CONCEPTT trial, published in 2017, showed that benefit in neonatal outcomes in women with type 1 diabetes using CGM during their antenatal care.
“I’m a huge advocate of using technology to help improve diabetes health outcomes and I’m delighted that we can offer CGMs to all expectant women with type 1 diabetes, after the proposed start in April was delayed by COVID-19. I feel the technology is going to make a huge improvement and also means pregnant women might be able to relax a little bit leaving them with more time to enjoy the pregnancy experience.”